- US Bank Profits Could Be Hurt by Financial Reforms
- World Bank Raises 2009 China GDP Forecast, Still Wary
- S&P Cuts Rating On 18 Banks, Dims Outlook on 4 Others
- China Eastern Agrees to Buy 20 Airbus A320s
- Powerful Indicators Suggest Correction On Horizon
- Cramer: It’s Time to Buy Health Care
- Icahn Raises Lions Gate Stake Again, Shares Surge
- Kudlow: Fed Overseeing Systemic Risk? What a Mess
- Faber Report: Behind Big Hedge Funds Signing Off
- Lightning Round OT: CarMax, FMC Tech and More
- Natural Gas Prices: True Demand or Market Manipulation?
- Mad Mail: McDonald’s or Wendy’s?
- Cramer: It’s Time to Buy Health Care
- This Week’s Sell-Off Explained
- Your First Move For Thursday June 18th
- Web Extra: Oil Snaps 3-Day Losing Streak
- Tweeting For Profits
- Your Questions About... Microsoft, Banks & More...
- World Bank raises China 2009 growth forecast
- House votes on Tenn. budget proposal
- Report: Health care costs to rise 9 pct in 2010
- Dungeons & Dragons handbooks subject of lawsuits
- Kan. lottery considers high-priced, lavish casinos
- LaHood offers plan to fund highway programs
- Mayo Clinic to come to Mall of America
- US doctors signal they'll work with Obama
- Quicksilver to sell $425 mln in bonds
Generex Biotechnology offering 17.2 million shares
WORCESTER, Mass. - Generex Biotechnology Corp. said Tuesday it expects to complete a registered offering of 17.2 million common shares.
The company is offering the stock at just under 64 cents per share, which would bring in proceeds of about $11 million. Shares closed at 76 cents per share Friday. After hours, following the announcement on the offering, the stock fell 5 cents, or 9.2 percent, to 69 cents. Generex has about 135.5 million shares of common stock outstanding.
Also, the company will provide 50 percent warrant coverage, exercisable beginning 183 days following the closing date for a period ending on the fifth anniversary of the initial exercise date. The warrants will have an exercise price of 76 cents per share.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.




